Bio Green Med Solution, Inc. — Director's Dealing 2015

Feb 20, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2015-02-18

Reporting Person: Chiao Judy (V.P., Clin. Dev. & Reg. Aff.)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-18	Option	$0.86	A	42940	Acquired	2025-02-18	Common Stock (42940)	Direct

Footnotes

F1: These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.

F2: These securities were granted to Judy Chiao under the Issuer's Amended and Restated 2006 Equity Incentive Plan as part of the Issuer's annual equity compensation to executive officers.